Kewaunee Scientific (KEQU) Liabilities and Shareholders Equity (2011 - 2026)

Kewaunee Scientific has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $176.0 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 6.97% year-over-year to $176.0 million; the trailing twelve-month figure through Jan 2026 stood at $753.2 million (up 27.57% YoY), and the FY2025 full-year result was $194.7 million, up 44.44% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $176.0 million, down from $189.1 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $194.7 million in Q2 2025, with the low at $95.7 million in Q1 2022.
• Average Liabilities and Shareholders Equity over 5 years is $142.1 million, with a median of $126.3 million recorded in 2024.
• Year-over-year, Liabilities and Shareholders Equity jumped 49.75% in 2025 and decreased 6.97% in 2026.
• Tracing KEQU's Liabilities and Shareholders Equity over 5 years: stood at $119.1 million in 2022, then advanced by 2.17% to $121.7 million in 2023, then advanced by 10.49% to $134.5 million in 2024, then surged by 40.6% to $189.1 million in 2025, then slipped by 6.94% to $176.0 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $176.0 million (Q1 2026), $189.1 million (Q4 2025), and $193.5 million (Q3 2025), per Business Quant data.

Peer Comparison